150 related articles for article (PubMed ID: 18537922)
1. Comparison of the risk of viral infection between the living and nonliving musculoskeletal tissue donors in Australia.
Yao F; Seed C; Farrugia A; Morgan D; Wood D; Zheng MH
Transpl Int; 2008 Oct; 21(10):936-41. PubMed ID: 18537922
[TBL] [Abstract][Full Text] [Related]
2. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
4. Trends in prevalence of viral infections in Australian musculoskeletal tissue donors and projections of incidence and residual risk, 1993-2004.
Yao F; Seed C; Kiely P; Parker S; Qian Y; Farrugia A; Morgan D; Wood D; Zheng MH
Transplantation; 2008 Sep; 86(5):746-8. PubMed ID: 18791459
[No Abstract] [Full Text] [Related]
5. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
6. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
7. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
8. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
[TBL] [Abstract][Full Text] [Related]
9. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
[TBL] [Abstract][Full Text] [Related]
11. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
[TBL] [Abstract][Full Text] [Related]
12. Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid.
Strong DM; Nelson K; Pierce M; Stramer SL
Cell Tissue Bank; 2005; 6(4):255-62. PubMed ID: 16308764
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool.
Donoso Mantke O; Meyer R; Prösch S; Nitsche A; Leitmeyer K; Kallies R; Niedrig M
J Heart Lung Transplant; 2005 Oct; 24(10):1632-8. PubMed ID: 16210141
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Challine D; Chevaliez S; Pawlotsky JM
Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
[TBL] [Abstract][Full Text] [Related]
16. [Removal and storage of human bone for transplantation. Directives for infection control].
Angermann P; Jepsen OB
Ugeskr Laeger; 1992 Feb; 154(6):336-9. PubMed ID: 1539364
[TBL] [Abstract][Full Text] [Related]
17. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.
Ahn J; Cohen SM
Liver Transpl; 2008 Nov; 14(11):1603-8. PubMed ID: 18975294
[TBL] [Abstract][Full Text] [Related]
18. Failure and success of HIV tests for the prevention of HIV-1 transmission by blood and tissue donations.
Najioullah F; Barlet V; Renaudier P; Guitton C; Crova P; Guérin JC; Peyramond D; Trabaud MA; Coudurier N; Tardy JC; André P
J Med Virol; 2004 Jul; 73(3):347-9. PubMed ID: 15170627
[TBL] [Abstract][Full Text] [Related]
19. A method for estimating incidence rate of infectious diseases among first-time blood donors.
Zou S; Fang CT; Dodd RY
Transfusion; 2008 Sep; 48(9):1827-32. PubMed ID: 18482184
[TBL] [Abstract][Full Text] [Related]
20. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
Maresch C; Schluter PJ; Wilson AD; Sleigh A
Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
